MDS Announces Special Meeting of Shareholders and Record Date
04 Septembre 2009 - 2:00PM
PR Newswire (US)
TORONTO, Sept. 4 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a leading provider of products and services to the
global life-sciences markets, today announced that the Company has
scheduled a Special Meeting of Shareholders to seek approval of the
proposed sale of MDS Analytical Technologies to Danaher Corporation
(NYSE:DHR). The meeting, which will commence at 4 p.m., will be
held on October 20, 2009 at the Toronto Congress Centre. The record
date for the purpose of determining shareholders entitled to
receive notice of, and to vote at, the Special Meeting is September
14, 2009. The MDS Board of Directors believes the proposed sale of
MDS Analytical Technologies to Danaher is in the best interests of
the Company and its shareholders, and unanimously recommends that
shareholders vote in favor of the sale. MDS expects that a
Management Proxy Circular for the shareholder meeting will be
mailed to shareholders later this month and will be available at
http://www.sedar.com/, http://www.sec.gov/edgar.shtml and
http://www.mdsinc.com/. The Management Proxy Circular will provide
important information about the proposed transaction as well as
information related to voting procedures. About MDS MDS Inc. (TSX:
MDS; NYSE: MDZ) is a global life sciences company that provides
market-leading products and services that our customers need for
the development of drugs, and the diagnosis and treatment of
disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging,
radiotherapeutics, and analytical instruments. MDS has more than
4,200 highly skilled people in 13 countries. Find out more at
http://www.mdsinc.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: MEDIA: Janet Ko, (905) 267-4226,
; INVESTORS: Kim Lee, (905) 267-4230,
Copyright